Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?

scientific article published on 01 November 2000

Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/ARCHSURG.135.11.1329
P698PubMed publication ID11074891

P2093author name stringJ Y Wu
I S Sheen
B F Chen
K S Jeng
P433issue11
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)1329-1333
P577publication date2000-11-01
P1433published inArchives of SurgeryQ15764793
P1476titleIs the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?
P478volume135

Reverse relations

cites work (P2860)
Q36065565Are gap junction gene connexins 26, 32 and 43 of prognostic values in hepatocellular carcinoma? A prospective study
Q34382605Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma
Q83956863Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma
Q34382580Do the expressions of gap junction gene connexin messenger RNA in noncancerous liver remnants of patients with hepatocellular carcinoma correlate with postoperative recurrences?
Q36474130Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection?
Q35048768Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?
Q33680701Molecular genetics of hepatocellular neoplasia.
Q24685729Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89
Q36308536P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection
Q34926255Preclinical evaluation of 4-methylthiobutyl isothiocyanate on liver cancer and cancer stem cells with different p53 status
Q37564060Prognostic significance of p53, mTOR, c-Met, IGF-1R, and HSP70 overexpression after the resection of hepatocellular carcinoma
Q36474101Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study
Q35810123Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature
Q41823983Successful management of postoperative recurrence of hepatocellular carcinoma with p53 gene therapy combining transcatheter arterial chemoembolization
Q78690326Telomerase expression and p53 status in hepatocellular carcinoma
Q34668320The prognostic molecular markers in hepatocellular carcinoma
Q80554209[Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology]
Q34884726p53 gene therapy in combination with transcatheter arterial chemoembolization for HCC: one-year follow-up

Search more.